Department of Nutrition, the Second Affiliated Hospital, Army Military Medical University, 400037 Chongqing.
Research Center for Nutrition and Food Safety, Chongqing Key Laboratory of Nutrition and Food Safety, Institute of Military Preventive Medicine, Army Military Medical University, Chongqing, The sixth medical center of PLA General Hospital, 100142 Beijing.
Phytomedicine. 2023 Jan;108:154509. doi: 10.1016/j.phymed.2022.154509. Epub 2022 Oct 18.
Estrogen deficiency is the leading cause of postmenopausal osteoporosis(PMOP) and phytoestrogens soy isoflavones (SI) have been shown to improve PMOP. Equol (Eq), an in vivo metabolite of phytoestrogens soy isoflavones (SI), has a more stable structure and stronger biological activity than its parent compound and has the greatest estrogenic activity. However, there are few studies on the therapeutic effect of Eq on PMOP.
To explore the therapeutic effect and mechanisms of Eq on POMP.
Osteoblast-like cells ROS1728 were cultured with different doses of Eq, estradiol (E2), separately. The effect of Eq on the proliferation, apoptosis, cell cycle of osteoblasts were detected by CCK-8 and flow cytometry, and the expression of OPG/RANK/RANKL signaling pathway of osteoblasts was detected by Quantitative real-time PCR (qRT-PCR) and Western blot (WB), and RNA silencing technology were carried out to explore the receptors through which Eq plays a role. Then PMOP rat model was established and treated by Eq or E2 to further verification of the effect and mechanism of Eq on PMOP.
Eq promoted the proliferation and inhibited the apoptosis of osteoblasts and increased the proportion of osteoblasts in the S phase and G2/M phase in a dose-dependent manner. Mechanistically, Eq treatment upregulated the expression of OPG and OPG/RANKL ratio in osteoblasts and this regulatory effect was mainly mediated through the ERβ receptor. Furthermore, in vivo study, Eq improved microstructure and BMD of the femur of PMOP rat model, which imitated the osteoprotective effect of E2. Moreover, the Eq or E2 treatment increased serum levels of Ca, 1,25(OH)2D3, bone Gla-protein(BGP), and Type I procollagen (PC1), and reduced serum levels of phosphorus (P), parathyroid hormone(PTH), pyridinol (PYD), tartrate-resistant acid phosphatase (TRAP) and urinary level of deoxypyridinoline (DPD) in the treatment OVX group compared with the untreated OVX group. Meanwhile, Eq or E2 markedly induced the mRNA and protein expression of OPG and OPG/RANKL ratio.
Eq can combine with ERβ and exert a protective effect on PMOP by upregulating OPG/RANKL pathway.
雌激素缺乏是绝经后骨质疏松症(PMOP)的主要原因,植物雌激素大豆异黄酮(SI)已被证明可改善 PMOP。雌马酚(Eq)是植物雌激素大豆异黄酮(SI)的体内代谢物,其结构比母体化合物更稳定,生物活性更强,具有最大的雌激素活性。然而,关于 Eq 对 PMOP 的治疗效果的研究很少。
探讨 Eq 对 POMP 的治疗作用及机制。
用不同剂量的 Eq 和雌二醇(E2)分别培养成骨样细胞 ROS1728。用 CCK-8 和流式细胞术检测 Eq 对成骨细胞增殖、凋亡、细胞周期的影响,用定量实时 PCR(qRT-PCR)和 Western blot(WB)检测成骨细胞 OPG/RANK/RANKL 信号通路的表达,并通过 RNA 沉默技术探讨 Eq 发挥作用的受体。然后建立 PMOP 大鼠模型,并通过 Eq 或 E2 进行治疗,进一步验证 Eq 对 PMOP 的作用及机制。
Eq 呈剂量依赖性地促进成骨细胞增殖,抑制成骨细胞凋亡,增加成骨细胞 S 期和 G2/M 期的比例。在机制上,Eq 处理上调了成骨细胞中 OPG 的表达和 OPG/RANKL 比值,这种调节作用主要是通过 ERβ 受体介导的。此外,体内研究表明,Eq 改善了 PMOP 大鼠模型股骨的微观结构和 BMD,模仿了 E2 的骨保护作用。此外,Eq 或 E2 治疗可增加血清中钙、1,25(OH)2D3、骨钙素(BGP)和 I 型前胶原(PC1)的水平,降低血清磷(P)、甲状旁腺激素(PTH)、吡啶酚(PYD)、抗酒石酸酸性磷酸酶(TRAP)和尿脱氧吡啶啉(DPD)的水平在未经处理的 OVX 组与未经处理的 OVX 组相比,OVX 组。同时,Eq 或 E2 显著诱导了 OPG 和 OPG/RANKL 比值的 mRNA 和蛋白表达。
Eq 可以与 ERβ 结合,通过上调 OPG/RANKL 通路对 PMOP 发挥保护作用。